Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of BIIB074 and Oral Contraceptives
NCT03324685Phase 1Completed
- Sponsor
- Biogen
- Start
- Nov 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vixotrigine in trigeminal neuralgia (TN) and small fiber neuropathy (SFN), sponsored by Biogen. Primary endpoints: Area Under the Concentration-Time Curve from Hour 0 to Hour 8, Area Under the Concentration-Time Curve from Hour 0 to Hour 24 and 5 more. Started Nov 2017; status: completed.
02
Drugs
vixotrigine
03
Conditions
trigeminal neuralgia (TN)small fiber neuropathy (SFN)
Beyond the preview
Go deeper on NCT03324685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03324685.